102 related articles for article (PubMed ID: 1100342)
21. [Risks in the treatment of parkinsonism with l-dopa and a dopa decarboxylase inhibitor].
Jörg J
Med Welt; 1979 Nov; 30(46):1740-2. PubMed ID: 537499
[No Abstract] [Full Text] [Related]
22. A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease.
Martin WE; Loewenson RB; Resch JA; Baker AB
Neurology; 1974 Oct; 24(10):912-9. PubMed ID: 4606107
[No Abstract] [Full Text] [Related]
23. Patterns of response to levodopa in Parkinson's disease.
Vajda FJ; Donnan GA; Bladin PF
Clin Exp Neurol; 1978; 15():299-306. PubMed ID: 756020
[TBL] [Abstract][Full Text] [Related]
24. [Results after 3 to 5 years of treatment of 219 cases of Parkinson's syndrome treated by L-Dopa and an L-Dopa -decarboxylase inhibitor combination].
Boudin G; Pepin B; Guillard A; Godlewski S; Fabiani JM; Haguenau M
Rev Neurol (Paris); 1974; 130(7-8):273-84. PubMed ID: 4217929
[No Abstract] [Full Text] [Related]
25. The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis.
Foster HD; Hoffer A
Med Hypotheses; 2004; 62(2):177-81. PubMed ID: 14962622
[TBL] [Abstract][Full Text] [Related]
26. Adverse reactions during treatment of Parkinson's disease with levodopa.
Martin WE
JAMA; 1971 Jun; 216(12):1979-83. PubMed ID: 5314258
[No Abstract] [Full Text] [Related]
27. L-dopa. II.
Br Med J; 1970 Nov; 4(5734):541-2. PubMed ID: 4099003
[No Abstract] [Full Text] [Related]
28. [L-dopa-induced psychoses and their treatment with L-tryptophan].
Demling J
Fortschr Med; 1986 Apr; 104(17):360-2. PubMed ID: 3710403
[No Abstract] [Full Text] [Related]
29. L-dopa therapy in Parkinson's disease.
Lipman IJ
Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138
[No Abstract] [Full Text] [Related]
30. [Therapy and problems of parkinsonism].
Albert E
Nervenarzt; 1971 May; 42(5):225-41. PubMed ID: 4942900
[No Abstract] [Full Text] [Related]
31. [Comparison between EEG-finding and clinical picture in patients with Parkinsonism under L-dopa].
Bengesser G
Wien Med Wochenschr; 1975 Feb; 125(7-8):120-1. PubMed ID: 1146347
[No Abstract] [Full Text] [Related]
32. [Experience with a l-dopa retard preparation in the peroral long-term therapy of the Parkinsonian syndrome].
Binder H; Gerstenbrand F; Grünberger J; Gründig E; Schubert H
Nervenarzt; 1976 Nov; 47(11):656-60. PubMed ID: 826840
[No Abstract] [Full Text] [Related]
33. [Aspects of long-term treatment with levodopa alone and levodopa combined with dopa decarboxylase inhibitors].
Cinca I; Serbănescu A; Tudorache B
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(4):261-70. PubMed ID: 6222452
[No Abstract] [Full Text] [Related]
34. Psychiatric aspects of L-dopa therapy of Parkinson's disease.
Pearlman CA; Sax DS; Feldman RD
Psychiatry Med; 1972 Jan; 3(1):45-50. PubMed ID: 4679766
[No Abstract] [Full Text] [Related]
35. L-dopa and tricyclic antidepressants in affective disorders. A pilot study.
Kabes J; Taussigová D; Dostál T; Vinar O
Act Nerv Super (Praha); 1974 Aug; 16(3):186-8. PubMed ID: 4473014
[No Abstract] [Full Text] [Related]
36. A double-blind comparison of levodopa, Madopa, and Sinemet in Parkinson disease.
Diamond SG; Markham CH; Treciokas LJ
Ann Neurol; 1978 Mar; 3(3):267-72. PubMed ID: 352236
[TBL] [Abstract][Full Text] [Related]
37. Zotepine in levodopa-induced Psychosis.
Spieker S; Stetter F; Klockgether T
Mov Disord; 1995 Nov; 10(6):795-7. PubMed ID: 8750001
[No Abstract] [Full Text] [Related]
38. [A case of mental change resulting from L-dopa treatment].
Gulmann NC
Ugeskr Laeger; 1976 Oct; 138(41):2497-8. PubMed ID: 973254
[No Abstract] [Full Text] [Related]
39. Dystonia induced by combined treatment with L-dopa and MK-801 in parkinsonian monkeys.
Rupniak NM; Boyce S; Steventon MJ; Iversen SD; Marsden CD
Ann Neurol; 1992 Jul; 32(1):103-5. PubMed ID: 1642462
[TBL] [Abstract][Full Text] [Related]
40. [Clinical aspects and pathogenesis of the "on-off" phenomenon in Parkinson syndrome].
Jörg J; Schneider I
Fortschr Neurol Psychiatr; 1988 Jan; 56(1):22-34. PubMed ID: 3126121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
